Cytokinetics, Incorporated Total Debt 1999–2025
Cytokinetics, Incorporated reported $246.38M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 60.2% lower than fiscal 2024. Compared with fiscal 2020, the change was +433.2%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $246.38M | -60.2% |
| FY 2024 | $619.52M | -3.1% |
| FY 2023 | $639.27M | -1.6% |
| FY 2022 | $649.56M | +1271.3% |
| FY 2021 | $47.37M | +2.5% |
| FY 2020 | $46.21M | +2.6% |
| FY 2019 | $45.05M | +6.2% |
| FY 2018 | $42.41M | +33.5% |
| FY 2017 | $31.78M | +6.3% |
| FY 2016 | $29.88M | +104.1% |
| FY 2015 | $14.64M | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | — |
| FY 2009 | $0 | — |
| FY 2008 | $0 | — |
| FY 2007 | $0 | — |
| FY 2006 | $0 | — |
| FY 2005 | $0 | — |
| FY 2004 | $0 | — |
| FY 2003 | $0 | — |
| FY 2002 | $0 | — |
| FY 2001 | $0 | — |
| FY 2000 | $0 | — |
| FY 1999 | $0 | — |
Source: Cytokinetics, Incorporated SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CYTK 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Cytokinetics, Incorporated reported $246.38M of total debt (short- plus long-term borrowings) for fiscal 2025. That was 60.2% lower than fiscal 2024. Compared with fiscal 2020, the change was +433.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Cytokinetics, Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCytokinetics, Incorporated — frequently asked questions
What is Cytokinetics, Incorporated's total debt (short- plus long-term borrowings)?
Cytokinetics, Incorporated (CYTK) reported total debt (short- plus long-term borrowings) of $246.38M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Cytokinetics, Incorporated's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.
More CYTK financial history
Full CYTK fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →